Genflow Biosciences PLC Sustainability Reports
Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative gene therapies designed to target and slow the aging process. The company researches biological interventions to reduce the incidence of age-related diseases in both humans and dogs.
Sector: Professional & technical services
Country: United Kingdom
Exchange: London Stock Exchange
LEI: 213800HVOFXRXVEGDN62
FIGI: BBG014GSK838
6 reports from 2021 to 2025
- Genflow Biosciences PLC 2025 Annual Report and Financial Statements
- Genflow Biosciences PLC 2024 Annual Report and Financial Statements
- Genflow Biosciences PLC 2023 Full Text of Final Accounts
- Genflow Biosciences PLC 2023 Annual Report and Financial Statements
- Genflow Biosciences PLC 2022 Annual Report and Financial Statements
